Understanding reimbursement is a growing challenge. Legislative and regulatory changes
happen frequently. Policies must be monitored at the national and the local level.
There are multiple coverage and payment systems within a single payor. Transparency
across Medicare, Managed Care and Medicaid is increasing. Employers continue to exert
influence on coverage and utilization rules

Economic influencers are critical customers and should be treated appropriately. The
biotechnology, medical device and pharmaceutical industries must work to ensure that this
segment receives the same focus as patients and providers. Our proven approach is based
on developing the messages and data needed for payors and employers tosupport the
appropriate coverage and payment of a product or a procedure across its lifecycle.

Health economics and reimbursement enable a manufacturer’s value proposition.